•Frederic Moll, who is known as the “Bill Gates of robotics,” ushered in the first wave of surgical robotics in 1995 with his company Intuitive Surgical and its Da Vinci systems.
•He has a new start-up called Auris Health that’s helping doctors diagnose lung cancer as early as possible using second generation robotics.
•Roughly 19% of people who are diagnosed with lung cancer will only survive 5 years, but if you catch it early that number jumps to 56%, according to research from the American Lung Association.
Frederic H. Moll trained to become a surgeon, but never completed his residency at Virgina Mason Hospital in Seattle. Nonetheless, the doctor-by-training and humble “gadget guy,” has changed the face of medicine for good.
Moll, who is known as the “Bill Gates of robotics,” ushered in the first wave of surgical robotics in 1995 with his company Intuitive Surgical and its Da Vinci systems. That business is now publicly traded with a market value around $51 billion.
But Moll has started a new venture, his fourth, called Auris Health in Redwood City, California. There, he is creating a “second generation of robotic capability” for doctors, he says.
For the unfamiliar, Moll and his team built the Da Vinci surgical systems in the early 90s to help surgeons do their work in a minimally invasive way. These large robots translate the movements of a surgeon’s hands into smaller, more precise motions.
“That was complicated when we did it,” Moll says. “And the challenge was two-fold. We were pushing the capability of robotics as they existed at that time. And we were really fighting from a conceptual standpoint to convince people it was a reasonable idea to use robots in surgery.”
Image Credit: CNBC
News This Week
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]